H. Lundbeck A/S (CPH:HLUN.B)
Denmark
· Delayed Price · Currency is DKK 40.00
+0.44 (1.11%)
Feb 28, 2025, 4:59 PM CET
H. Lundbeck Revenue
In the year 2024, H. Lundbeck had annual revenue of 22.00B DKK with 10.51% growth. H. Lundbeck had revenue of 5.54B in the quarter ending December 31, 2024, with 11.31% growth.
Revenue
22.00B
Revenue Growth
+10.51%
P/S Ratio
1.80
Revenue / Employee
3.86M
Employees
5,707
Market Cap
38.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 290.40B |
| Coloplast | 27.45B |
| Genmab | 21.53B |
| Demant | 22.42B |
| Zealand Pharma | 62.69M |
| Ambu A/S | 5.65B |
| ALK-Abelló | 5.54B |
| GN Store Nord | 17.99B |